Knight JD - Search Results

1

Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry.

Mark DB, O'Neill WW, Brodie B, Ivanhoe R, Knopf W, Taylor G, O'Keefe JH, Grines CL, Davidson-Ray L, Knight JD, et al. Mark DB, et al. Among authors: knight jd. J Am Coll Cardiol. 1995 Sep;26(3):688-95. doi: 10.1016/0735-1097(95)00246-z. J Am Coll Cardiol. 1995. PMID: 7642860 Free article. Clinical Trial.

2

Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.

Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing NE, et al. Mark DB, et al. Among authors: knight jd. N Engl J Med. 1994 Oct 27;331(17):1130-5. doi: 10.1056/NEJM199410273311706. N Engl J Med. 1994. PMID: 7935638 Free article.

3

Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application.

Eisenstein EL, Peterson ED, Jollis JG, Tardiff BE, Califf RM, Knight JD, Mark DB. Eisenstein EL, et al. Among authors: knight jd. Proc AMIA Annu Fall Symp. 1997:273-7. Proc AMIA Annu Fall Symp. 1997. PMID: 9357631 Free PMC article.

4

Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.

Tung CY, Granger CB, Sloan MA, Topol EJ, Knight JD, Weaver WD, Mahaffey KW, White H, Clapp-Channing N, Simoons ML, Gore JM, Califf RM, Mark DB. Tung CY, et al. Among authors: knight jd. Circulation. 1999 Jan 26;99(3):370-6. doi: 10.1161/01.cir.99.3.370. Circulation. 1999. PMID: 9918523

5

A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications.

Batchelor WB, Peterson ED, Mark DB, Knight JD, Granger CB, Armstrong PW, Califf RM. Batchelor WB, et al. Among authors: knight jd. J Am Coll Cardiol. 1999 Jul;34(1):12-9. doi: 10.1016/s0735-1097(99)00174-6. J Am Coll Cardiol. 1999. PMID: 10399985 Free article.

6

Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome.

Eisenstein EL, Peterson ED, Jollis JG, Tardiff BE, Califf RM, Knight JD, Mark DB. Eisenstein EL, et al. Among authors: knight jd. Pharmacoeconomics. 2000 Mar;17(3):263-72. doi: 10.2165/00019053-200017030-00004. Pharmacoeconomics. 2000. PMID: 10947301

7

Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.

Lincoff AM, Mark DB, Tcheng JE, Califf RM, Bala MV, Anderson KM, Davidson-Ray L, Knight JD, Cabot CF, Topol EJ. Lincoff AM, et al. Among authors: knight jd. Circulation. 2000 Dec 12;102(24):2923-9. doi: 10.1161/01.cir.102.24.2923. Circulation. 2000. PMID: 11113041 Clinical Trial.

8

Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.

Batchelor WB, Mark DB, Knight JD, Granger CB, Armstrong PW, Califf RM, Peterson ED. Batchelor WB, et al. Among authors: knight jd. Am Heart J. 2003 Feb;145(2):349-55. doi: 10.1067/mhj.2003.111. Am Heart J. 2003. PMID: 12595855

9

Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.

Kaul P, Armstrong PW, Fu Y, Knight JD, Clapp-Channing NE, Sutherland W, Granger CB, Mark DB; GUSTO-IIb investigators. Kaul P, et al. Among authors: knight jd. Can J Cardiol. 2004 Jun;20(8):760-6. Can J Cardiol. 2004. PMID: 15229756 Clinical Trial.

10

Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.

Mark DB, Knight JD, Cowper PA, Davidson-Ray L, Anstrom KJ. Mark DB, et al. Among authors: knight jd. Am Heart J. 2008 Oct;156(4):698-705. doi: 10.1016/j.ahj.2008.05.032. Epub 2008 Sep 5. Am Heart J. 2008. PMID: 18926150 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page